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Background
Multiple sclerosis (MS) is a central nervous system demy-
elinating disease usually diagnosed on the basis of typical
neurological symptoms and signs, clinical course, and
laboratory and neuroradiological findings. Psychiatric
symptoms and disorders frequently co-occur in MS.
Materials and methods
We examined the evidence of correlation between relapses
of the comorbid psychosis in a multiple sclerosis (MS)
patient and progression of the disease. This case report
also deals with the antipsychotic treatment and his neces-
sary modifications.
Results
We present a case of a 35 years old male affected by mul-
tiple sclerosis in the last 6 years under treatment with
interferons. One year after the diagnosis of the demyeli-
nating disease, the patient developed psychiatric manifes-
tations and he referred to a psychiatric clinic where was
formulated the diagnosis of psychosis. There was no fam-
ily or personal history of psychiatric disease or psycho-
tropic medication/substance use. The patient initially has
been treated with risperidone and with an exception of a
relapse, because of non-compliance, has been almost sta-
ble for about 5 years. At the age of 35 years he has been
recovered to our clinic due to a severe exacerbation of the
psychosis which persistent symptoms leaded to a change
of the antipsychotic treatment. Initially he began on
sertindole for one month with poor response. Thus he has
changed treatment and the following administration of
clozapine had as a result the remission of the symptoms.
Conclusions
The progression of the MS frequently comports exacerba-
tion of the symptomatology of the comorbid psychosis.
Clozapine seems to constitute a valid treatment.
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